Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01143870 · ClinicalTrials.gov registry record · NA
New Ways to Help Patients Improve Their Diabetes Control
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
NCT01143870: Completed NA study, sponsored by University of Pennsylvania.
NCT01143870 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 177 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01143870, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
Study Summary
The percent of glycosylated hemoglobin, also known as a hemoglobin A1C value, is the standard way that clinicians assess a patient's diabetes control. Numerous studies have shown that maintaining a hemoglobin A1C value less than 7% is associated with lower rates of diabetes-related complications. Clinicians use this value to determine whether a patient with diabetes requires changes in their disease management. The main problem with this practice is that many patients do not understand what this number means. The goal of this project is to examine ways to make feedback about glycemic control easier for patients to understand. The hope is that improved patient understanding will result in an improvement in diabetic control and thus a reduction in disease-associated complications. Patients with a diagnosis of diabetes and a hemoglobin A1C value greater than 8% within the preceding three months will be eligible for the study. Pregnant women will be excluded. Given the nature of the intervention we will also exclude patients with cognitive deficits. In this study, patients will be randomized to three groups. The first group with be told their HgbA1C value only, the second group will be told a letter grade interpretation of that value, and the third group will be shown a face. The face emotions will range from happy to sad reflecting the level of control. The main outcome will be trend in hemoglobin A1C values over time. Secondary outcomes will include patient understanding of disease state and the number of hemoglobin A1C values checked following the intervention.
Interventions
- OTHER "Diabetes Report Card"
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2010-04 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01143870
The ClinicalTrials.gov registry entry for NCT01143870 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which "Diabetes Report Card" is the first listed.
NCT01143870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01143870 about?
NCT01143870 is a clinical study titled "New Ways to Help Patients Improve Their Diabetes Control". The percent of glycosylated hemoglobin, also known as a hemoglobin A1C value, is the standard way that clinicians assess a patient's diabetes control. Numerous studies have shown that maintaining a hemoglobin A1C value less than 7% is associated with lower rates of diabetes-related complications. Cl...
What is the current status of trial NCT01143870?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2010-04. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01143870?
The interventions under investigation include: "Diabetes Report Card" (OTHER).
Who is sponsoring clinical trial NCT01143870?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.